Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 16585
Country/Region: Central America Region
Year: 2016
Main Partner: University Research Corporation, LLC
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: HHS/CDC
Total Funding: $1,255,412 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $608,547
Care: TB/HIV (HVTB) $646,865
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 120
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 120
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 60
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 480
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 520
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 260
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 600
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 640
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 320
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 600
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 640
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 320
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 600
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 640
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 320
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 6
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 6
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 3
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 24
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 26
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 13
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 3
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that achieve acceptable successful passing criteria in this PT program 2017 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 3
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that participate in this PT program 2017 1
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 3
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 6
LAB_PT HIV serologic/diagnostic testing: Number of laboratories that perform this testing 2017 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 3
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 6
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 10
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 25
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 4
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 6
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 9
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 2
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2017 530
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2017 945
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2017 200
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 6
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 11
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 2
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 8
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 6
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 11
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 2
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 6
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 3
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 2
TB_SCREENDX Screen Results: Screened Positive for TB 2017 10
TB_SCREENDX Screen Results: Screened Positive for TB 2017 19
TB_SCREENDX Screen Results: Screened Positive for TB 2017 4
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 220
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 285
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 85
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 310
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 660
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 115
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 32
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 141
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 5
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 78
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 322
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 110
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 468
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 17
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 134
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 566
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 20
Cross Cutting Budget Categories and Known Amounts Total: $356,488
Human Resources for Health $356,488